HCA Healthcare, Inc. $HCA Shares Sold by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC cut its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 9.7% in the third quarter, HoldingsChannel.com reports. The fund owned 20,908 shares of the company’s stock after selling 2,242 shares during the period. Mutual of America Capital Management LLC’s holdings in HCA Healthcare were worth $8,911,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of HCA. Ameriflex Group Inc. purchased a new position in shares of HCA Healthcare in the second quarter valued at approximately $27,000. Chung Wu Investment Group LLC acquired a new stake in shares of HCA Healthcare in the second quarter valued at about $27,000. Clearstead Trust LLC grew its stake in HCA Healthcare by 311.8% during the 2nd quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after acquiring an additional 53 shares in the last quarter. Harbor Capital Advisors Inc. boosted its holdings in shares of HCA Healthcare by 82.9% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock worth $32,000 after purchasing an additional 34 shares during the last quarter. Finally, Twin Peaks Wealth Advisors LLC purchased a new position in HCA Healthcare during the second quarter worth approximately $40,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on HCA. Wells Fargo & Company boosted their price target on shares of HCA Healthcare from $431.00 to $452.00 and gave the company an “equal weight” rating in a research report on Wednesday, January 7th. Mizuho lifted their price target on shares of HCA Healthcare from $505.00 to $520.00 and gave the company an “outperform” rating in a research report on Thursday, December 18th. Sanford C. Bernstein reissued a “market perform” rating and set a $503.00 target price on shares of HCA Healthcare in a research note on Tuesday, January 6th. KeyCorp reissued an “overweight” rating and set a $500.00 price objective on shares of HCA Healthcare in a research report on Thursday, January 22nd. Finally, Oppenheimer increased their target price on shares of HCA Healthcare from $400.00 to $500.00 and gave the stock an “outperform” rating in a research note on Monday, October 27th. Fourteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $488.75.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Q4 EPS beat and solid operational performance: HCA reported $8.01 EPS vs. consensus ~ $7.37, driven by strong patient volumes and higher revenue per equivalent admission—this beat is the primary catalyst for the rally. HCA Healthcare (HCA) Beats Q4 Earnings Estimates
• Positive Sentiment: Big capital returns: HCA raised the quarterly dividend ~8.3% to $0.78 and authorized an additional $10 billion for buybacks — increases near-term shareholder cash returns and supports the stock. HCA Healthcare Raises Dividend by 8.3%, Adds $10 Billion to Stock Buyback
• Positive Sentiment: FY2026 profit outlook and cost savings: Management reiterated FY2026 EPS guidance (29.10–31.50) roughly in line with Street and outlined a $400M cost-savings plan that it says will boost profit—supporting forward earnings expectations. HCA Healthcare forecasts 2026 profit above estimates on medical care services demand
• Neutral Sentiment: Revenue slightly missed estimates: Q4 revenue was $19.51B vs. the ~$19.67B consensus—top-line growth was positive (+6.7% YoY) but slightly below Street expectations, which tempers the beat. HCA Healthcare earnings press release / transcript
• Neutral Sentiment: Management says it can navigate policy uncertainty, but the outlook depends on execution and payer developments. Why HCA says it can navigate 2026 policy uncertainty
• Negative Sentiment: Policy headwinds: HCA flagged roughly a $1 billion hit tied to the loss of ACA premium tax credit flow-through and Medicaid changes—this is a material near-term headwind to revenue/margins. HCA expects $1 billion hit from loss of ACA tax credits, Medicaid changes
• Negative Sentiment: Analyst caution on valuation and margin sustainability: Some analysts warn margins may be peaking and HCA’s valuation now reflects much of the improvement, noting downside risk if policy pressures or margin compression accelerate. HCA Healthcare: A Booming Buyback But Risks Loom (Downgrade)

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $506.29 on Wednesday. The firm’s 50-day moving average is $480.84 and its two-hundred day moving average is $435.90. HCA Healthcare, Inc. has a 1 year low of $295.00 and a 1 year high of $527.55. The firm has a market capitalization of $115.53 billion, a PE ratio of 19.57, a price-to-earnings-growth ratio of 1.30 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, topping the consensus estimate of $7.37 by $0.64. The firm had revenue of $19.51 billion for the quarter, compared to the consensus estimate of $19.67 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The firm’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same period in the prior year, the firm earned $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be paid a $0.78 dividend. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Tuesday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s dividend payout ratio (DPR) is 11.13%.

Insiders Place Their Bets

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the sale, the executive vice president owned 3,487 shares of the company’s stock, valued at $1,652,105.73. This trade represents a 52.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.30% of the stock is currently owned by company insiders.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.